SCHEMBL29454950

SCHEMBL29454950

CCOc1ccc(-c2c3nc(c(-c4ccc(OCC)cc4)c4ccc([nH]4)c(-c4ccc(OCC)cc4)c4nc(c(-c5ccc(OCC)cc5)c5ccc2[nH]5)C=C4)C=C3)cc1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ TERT O14746 4/20 0.55
▸ TOP1 P11387 4/20 0.51
▸ CYCS P99999 3/20 0.50
▸ ABCG2 Q9UNQ0 1/20 0.49
▸ ENPP2 Q13822 1/20 0.49
▸ KDM4E B2RXH2 2/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ GAA P10253 1/20 0.44
▸ HPGD P15428 1/20 0.44
▸ ALOX15 P16050 1/20 0.44
▸ MPI P34949 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ NQO1 P15559 1/20 0.44
▸ NPC1 O15118 1/20 0.43
▸ MAPT P10636 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17906212 0.91 TERT (0.47) TERTTOP1CYCSABCG2ENPP2
SCHEMBL25566046 0.91 TERT (0.47) TERTTOP1CYCSABCG2ENPP2
SCHEMBL17904265 0.87 TERT (0.47) TERTTOP1CYCSABCG2ENPP2
SCHEMBL31169674 0.85 TERT (0.50) TERTTOP1CYCSABCG2ENPP2
SCHEMBL12190732 0.84 TERT (0.49) TERTTOP1CYCSABCG2ENPP2
SCHEMBL8031578 0.84 TERT (0.49) TERTTOP1CYCSABCG2ENPP2
SCHEMBL2531376 0.84 TERT (0.49) TERTTOP1CYCSABCG2ENPP2
SCHEMBL16978969 0.84 TERT (0.49) TERTTOP1CYCSABCG2ENPP2
SCHEMBL8907605 0.83 ABCG2 (0.52) TERTTOP1CYCSABCG2ENPP2
SCHEMBL29414382 0.82 TERT (0.57) TERTTOP1CYCSABCG2ENPP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230023927-A1 IMMUNOGLOBULIN CHIMERIC MONOMER-DIMER HYBRIDS BIOVERATIV THERAPEUTICS INC (US) 2023-01-26 — — US disclosed
US-11401322-B2 Immunoglobulin chimeric monomer-dimer hybrids BIOVERATIV THERAPEUTICS INC. (US) 2022-08-02 — — US disclosed
EP-2361932-B2 Immunoglobulin chimeric monomer-dimer hybrids BIOVERATIV THERAPEUTICS INC (US) 2022-06-22 — — EP disclosed
EP-3978508-A1 IMMUNOGLOBULIN CHIMERIC MONOMER-DIMER HYBRIDS Bioverativ Therapeutics Inc. (US) 2022-04-06 — — EP disclosed
Send feedback